Humacyte, Inc. (HUMA) Barclays 28th Annual Global Healthcare Conference March 10, 2026 1:00 PM EDT
Company Participants
Laura Niklason – Founder, President, CEO & Director
Dale Sander – CFO, Chief Corporate Development Officer & Treasurer
Conference Call Participants
Matthew Miksic – Barclays Bank PLC, Research Division
Presentation
Matthew Miksic
Barclays Bank PLC, Research Division
All right. Well, we are a couple of minutes into our time here. So we’re going to have to talk fast, Laura.
Laura Niklason
Founder, President, CEO & Director
Okay.
Matthew Miksic
Barclays Bank PLC, Research Division
I am very pleased to have with us here at our conference Humacyte. Laura Niklason, Dr. Laura Niklason, Founder, President and Chief Executive Officer; and Dale Sander, CFO. So thank you for coming.
Question-and-Answer Session
Matthew Miksic
Barclays Bank PLC, Research Division
Just a quick snippet of history. I’ve told you before, I think we’ve met a long time ago in very early stages and I was fascinated by the technology and a lot of things happened from that meeting to like launching in the last year or 2. I feel like I’ve missed the hard part and showed up for the good part, the fun part, maybe. So but it’s been fun to see this develop over the years. So with that sort of prelude, the launch last year into vascular trauma and the cadence being vascular trauma dialysis and CABG, I guess, around figures. There were some excitement out of that, success, obviously, clinical success of the product, but also some learnings and some course corrections during the year. So maybe just catch us up to what you’ve learned, what you’ve changed and how you’re entering 2026.
Laura Niklason
Founder, President, CEO & Director
Yes. So thank you, Matt, for the opportunity to do this. So 2025 was the first year you launch
